129 related articles for article (PubMed ID: 9013833)
1. Immunohistochemical localization of p21(WAF1/CIP1) in normal, hyperplastic, and neoplastic uterine tissues.
Palazzo JP; Mercer WE; Kovatich AJ; McHugh M
Hum Pathol; 1997 Jan; 28(1):60-6. PubMed ID: 9013833
[TBL] [Abstract][Full Text] [Related]
2. Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis.
Lu X; Toki T; Konishi I; Nikaido T; Fujii S
Cancer; 1998 Jun; 82(12):2409-17. PubMed ID: 9635534
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity.
Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
J Pathol; 1996 Oct; 180(2):122-8. PubMed ID: 8976868
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus.
Bae DS; Cho SB; Kim YJ; Whang JD; Song SY; Park CS; Kim DS; Lee JH
Gynecol Oncol; 2001 Jun; 81(3):341-7. PubMed ID: 11371120
[TBL] [Abstract][Full Text] [Related]
5. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.
Lukas J; Groshen S; Saffari B; Niu N; Reles A; Wen WH; Felix J; Jones LA; Hall FL; Press MF
Am J Pathol; 1997 Jan; 150(1):167-75. PubMed ID: 9006333
[TBL] [Abstract][Full Text] [Related]
6. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations.
Yemelyanova A; Gown AM; Wu LS; Holmes BJ; Ronnett BM; Vang R
Int J Gynecol Pathol; 2014 Sep; 33(5):492-9. PubMed ID: 25083965
[TBL] [Abstract][Full Text] [Related]
7. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.
Kimura F; Watanabe J; Hata H; Fujisawa T; Kamata Y; Nishimura Y; Jobo T; Kuramoto H
J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303
[TBL] [Abstract][Full Text] [Related]
8. Expression of p21WAF1/CIP1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression.
Yasui W; Akama Y; Yokozaki H; Semba S; Kudo Y; Shimamoto F; Tahara E
Pathol Int; 1997 Jul; 47(7):470-7. PubMed ID: 9234386
[TBL] [Abstract][Full Text] [Related]
9. p53-independent expression of p21waf1/cip1 in preinvasive and invasive squamous neoplasms of the uterine cervix.
Werness BA; Wang HQ; Chance J; Goldstein DJ
Mod Pathol; 1997 Jun; 10(6):578-84. PubMed ID: 9195575
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma.
Cheng JD; Werness BA; Babb JS; Meropol NJ
Clin Cancer Res; 1999 May; 5(5):1057-62. PubMed ID: 10353738
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of p21WAF1/CIP1 and MDM2 characterizes serous borderline ovarian tumors.
Palazzo JP; Monzon F; Burke M; Hyslop T; Dunton C; Barusevicius A; Capuzzi D; Kovatich AJ
Hum Pathol; 2000 Jun; 31(6):698-704. PubMed ID: 10872663
[TBL] [Abstract][Full Text] [Related]
12. [Expression significance of P21WAF1/CIP1 protein in eye-lid primary malignant tumor].
Yue H; Zhang B
Yan Ke Xue Bao; 2001 Dec; 17(4):206-8. PubMed ID: 12567505
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
14. Expression of p21WAF1/CIP1 is heterogeneous and unrelated to proliferation index in human ovarian carcinoma.
Barboule N; Mazars P; Baldin V; Vidal S; Jozan S; Martel P; Valette A
Int J Cancer; 1995 Nov; 63(5):611-5. PubMed ID: 7591274
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
[TBL] [Abstract][Full Text] [Related]
16. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma.
Slebos RJ; Baas IO; Clement M; Polak M; Mulder JW; van den Berg FM; Hamilton SR; Offerhaus GJ
Br J Cancer; 1996 Jul; 74(2):165-71. PubMed ID: 8688317
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of p21Waf1/Cip1 and p53 in sun-exposed normal epidermis, but not in neoplastic epidermis.
Inohara S; Kitagawa K; Kitano Y
Br J Dermatol; 1996 Nov; 135(5):717-20. PubMed ID: 8977670
[TBL] [Abstract][Full Text] [Related]
19. Expression of p21WAF1/CIP1 in soft tissue sarcomas: a comparative immunohistochemical study with p53 and Ki-67.
Pindzola JA; Palazzo JP; Kovatich AJ; Tuma B; Nobel M
Pathol Res Pract; 1998; 194(10):685-91. PubMed ID: 9820864
[TBL] [Abstract][Full Text] [Related]
20. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]